Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Structure-based design of glycoprotein subunit vaccines for mumps
  2. Loomis, Rebecca J; Lai, Yen-Ting; Sowers, Sun B; Fisher, Brian; Derrien-Colemyn, Alexandrine; Ambrozak, David R; Tsybovsky,Yaroslav; Crooke, Stephen N; Latner, Donald R; Kong, Wing-Pui; Ruckwardt, Tracy J; Plotkin, Stanley A; Kwong, Peter D; Mascola, John R; Graham, Barney S; Hickman, Carole J; Stewart-Jones, Guillaume B E
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Nov 19; 121(47): e2404053121.
  1. 2.   An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant replication in rhesus macaques
  2. Sui, Yongjun; Li, Jianping; Andersen, Hanne; Zhang, Roushu; Prabhu, Sunaina K; Hoang, Tanya; Venzon, David; Cook, Anthony; Brown, Renita; Teow, Elyse; Velasco, Jason; Pessaint, Laurent; Moore, Ian N; Lagenaur, Laurel; Talton, Jim; Breed,Matthew; Kramer,Josh; Bock, Kevin W; Minai, Mahnaz; Nagata, Bianca M; Choo-Wosoba, Hyoyoung; Lewis, Mark G; Wang, Lai-Xi; Berzofsky, Jay A
  3. PNAS Nexus. 2022, Jul; 1(3): pgac091.
  1. 3.   A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
  2. Bossart, K. N.; Zhu, Z. Y.; Middleton, D.; Klippel, J.; Crameri, G.; Bingham, J.; McEachern, J. A.; Green, D.; Hancock, T. J.; Chan, Y. P.; Hickey, A. C.; Dimitrov, D. S.; Wang, L. F.; Broder, C. C.
  3. Plos Pathogens. 2009 5(10):
  1. 4.   Intranasal Protollin (TM)/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection
  2. Jones, T.; Adamovicz, J. J.; Cyr, S. L.; Bolt, C. R.; Bellerose, N.; Pitt, L. M.; Lowell, G. H.; Burt, D. S.
  3. Vaccine. 2006, Mar; 24(10): 1625-1632.
  1. 5.   Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
  2. Powell, B. S.; Andrews, G. P.; Enama, J. T.; Jendrek, S.; Bolt, C.; Worsham, P.; Pullen, J. K.; Ribot, W.; Hines, H.; Smith, L.; Heath, D. G.; Adamovicz, J. J.
  3. Biotechnology Progress. 2005, SEP-OCT; 21(5): 1490-1510.
  1. 6.   Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus
  2. Vande Woude, S.; Hageman, C. A.; O'Brien, S. J.; Hoover, E. A.
  3. Journal of acquired immune deficiency syndromes (1999). 2002 29(1): 1-10.
  1. 7.   Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: Effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses
  2. Kumar, A.; Lifson, J. D.; Silverstein, P. S.; Jia, F.; Sheffer, D.; Li, Z.; Narayan, O.
  3. Virology. 2000 274(1): 149-164.
  1. 8.   Protection from pathogenic SIV challenge using multigenic DNA vaccines
  2. Haigwood, N. L.; Pierce, C. C.; Robertson, M. N.; Watson, A. J.; Montefiori, D. C.; Rabin, M.; Lynch, J. B.; Kuller, L.; Thompson, J.; Morton, W. R.; Benveniste, R. E.; Hu, S. L.; Greenberg, P.; Mossman, S. P.
  3. Immunology Letters. 1999 66(1-3): 183-188.
  1. 9.   Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
  2. Sei, S.; Sandelli, S. L.; Theofan, G.; Ratto-Kim, S.; Kumagai, M.; Loomis-Price, L. D.; Cox, J. H.; Jarosinski, P.; Walsek, C. M.; Brouwers, P.; Venzon, D. J.; Xu, J.; Pizzo, P. A.; Moss, R. B.; Robb, M. L.; Wood, L. V.
  3. Journal of Infectious Diseases. 1999 180(3): 626-640.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel